Telescope Innovations Shares Spring 2026 Conference and Events Lineup
May 11, 2026 — The Company is actively engaging with pharmaceutical, academic, and investor audiences to strengthen existing and novel partnerships
Curzio Research Interviews Telescope CTO
April 20, 2026 — CTO Jason Hein tells Frank Curzio how our young company is changing the way Big Pharma performs R&D.
Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026
April 13, 2026 — Revenues are consistent with budget expectations and ahead of Q2 2025 comparative revenues.
Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation
March 23, 2026 — Dr. Hawkins will contribute to the development of automated reaction sampling technology and Self-Driving Labs.
Telescope Strengthens Investor Communications Strategy
March 12, 2026 — Telescoped has rescoped previously announced digital marketing agreements
Telescope Innovations to deliver first Self-Driving Lab for Korea’s largest biopharma manufacturers association
November 17, 2025 — Korea’s leading biopharma association selects Telescope’s Self-Driving Lab to anchor the country’s first AI-driven training hub.
Telescope Innovations conditionally approved for up to $3.36 M in government funding to advance lithium processing technology
November 4, 2025 — Federal support accelerates Telescope’s continued development, demonstration and scale-up of lithium recycling and solid-state battery materials technologies.
Telescope announces debt settlement transaction
October 23, 2025 — The Company has entered into agreements to settle certain outstanding indebtedness through the issuance of 689,654 common shares (each, a “Share”) of the Company (the “Debt Settlement”).
Telescope issues Stock Options and Shares for debt
October 15, 2025 — The Company has granted 1,544,000 incentive stock options (the “Options”) to certain directors, employees and consultants.
Telescope closes final tranche of private placement
October 14, 2025 — Gross proceeds of $1,296,704 were raised in this final tranche.
